Disabled doctors warn they are being denied reasonable adjustments across the NHS, putting careers, patient safety, and wellbeing at risk despite legal protections.
A breakthrough treatment for severe hay fever caused by birch pollen will soon be available on the NHS, as NICE recommends the first daily immunotherapy tablet for patients who don’t respond to standard therapies.
The UK has approved its first-ever needle-free adrenaline treatment for severe allergic reactions, marking a major development in how anaphylaxis could be managed in emergencies.
The UK Government has unveiled an enhanced support plan for people with ME/CFS, including NHS staff training, public awareness campaigns, and up to £200,000 in grants per research project.
The UK government has announced a strategy that will improve the country’s artificial intelligence (AI) capabilities by launching a new Compute Roadmap aimed at transforming Britain into an “AI maker”.
As the world races to meet urgent climate targets, voluntary carbon markets (VCMs) are gaining momentum as a vital tool to accelerate decarbonisation and unlock private climate finance.
The UK Government has announced a new update to the UK Internal Market Act, aimed at enhancing the way businesses trade across England, Scotland, Wales, and Northern Ireland.
The NHS will provide a new triple combination therapy to hundreds of children and adults with cystic fibrosis in England, aiming to improve lung function and quality of life for eligible patients.
The UK government is opening applications for a new $1 million fellowship that is expected to attract the country’s top AI engineers into public service.
The UK government has announced new changes to the national electricity markets with the hopes of creating a system that is fairer, more secure, and affordable for working families and businesses.
The government begins phase 1 of its 10 Year Health Plan, launching 42 pioneer neighbourhood health services in deprived areas to support those with complex needs at home.
